Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Sareum Holdings (RYH0) Stock Price & Analysis

RYH0 Stock Chart & Stats

€0.15€0.00(0.65%)
At close: 1:00 AM GMT+1
€0.15€0.2€0.2519 Feb14 Apr
Day’s Range
EUR 0.14 - EUR 0.15
52-Week Range
EUR 0.10 - EUR 0.38
Previous Close
EUR 0.15
Volume
N/A
Average Volume (3M)
0
Market Cap
EUR 29.90M
Enterprise Value
EUR 18.17M
Total Cash (Recent Filing)
EUR 2.49M
Total Debt (Recent Filing)
EUR 0
Price to Earnings (P/E)
―
Beta
-0.35
Next Earnings
Nov 02, 2026 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Clean Balance Sheet — No Reported Debt

A debt-free balance sheet materially reduces solvency and refinancing risk for an early-stage biotech. Without fixed interest burdens the company can direct limited capital to R&D and licensing efforts, extending runway and preserving strategic optionality during long development cycles.

Partnering/licensing-focused Business Model

A partnership/licensing model aligns with capital efficiency for small biotechs: value is realized through discrete deal milestones rather than commercial infrastructure. This structural model lets Sareum monetize assets via large pharma partners, reducing long-term commercialization risk and capex needs.

Focused R&D In TYK2/JAK Kinase Pathways

A concentrated scientific focus builds durable technical expertise and a coherent pipeline strategy. Specialization in TYK2/JAK small-molecule inhibitors targets validated biology with broad addressable markets in autoimmune/inflammatory diseases, improving the odds of attractive partner interest and licensing outcomes.

Bears Say

Pre-revenue With Persistent Operating Losses

Sustained operating losses mean the company cannot self-fund development and lacks commercial cash inflows. Over multiple periods this drains equity, forces dilution or costly financing, and increases execution risk if partners or capital are delayed, making long-term program progression contingent on external funding.

Significant Cash Burn; Negative Free Cash Flow

Persistent negative operating and free cash flow require repeated financing and constrain strategic flexibility. Even with recent narrowing, ongoing burn drives dependency on capital markets or partners, elevating dilution risk and potentially forcing prioritization or shelving of programs if funding conditions tighten.

High Dependence On Partnerships And Limited Internal Resources

Relying on external deals creates binary, milestone-driven outcomes; combined with small equity and a five-person team, Sareum may lack capacity and balance-sheet heft to advance multiple programs independently. This concentration amplifies execution and timing risk for durable growth.

Sareum Holdings News

RYH0 FAQ

What was Sareum Holdings’s price range in the past 12 months?
Sareum Holdings lowest stock price was €0.10 and its highest was €0.38 in the past 12 months.
What is Sareum Holdings’s market cap?
Sareum Holdings’s market cap is €29.90M.
When is Sareum Holdings’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Sareum Holdings’s earnings last quarter?
Sareum Holdings released its earnings results on Mar 12, 2026. The company reported -€0.014 earnings per share for the quarter.
Is Sareum Holdings overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Sareum Holdings pay dividends?
Sareum Holdings does not currently pay dividends.
What is Sareum Holdings’s EPS estimate?
Sareum Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sareum Holdings have?
Sareum Holdings has 163,604,750 shares outstanding.
What happened to Sareum Holdings’s price movement after its last earnings report?
Sareum Holdings reported an EPS of -€0.014 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Sareum Holdings?
Currently, no hedge funds are holding shares in DE:RYH0
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology